Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma.
Teishima J, Murata D, Yukihiro K, Sekino Y, Inoue S, Hayashi T, Mita K, Hasegawa Y, Kato M, Kajiwara M, Shigeta M, Maruyama S, Moriyama H, Fujiwara S, Matsubara A.
Teishima J, et al. Among authors: murata d.
Curr Urol. 2023 Mar;17(1):52-57. doi: 10.1097/CU9.0000000000000105. Epub 2022 Aug 2.
Curr Urol. 2023.
PMID: 37692134
Free PMC article.